Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2021

Aug 16, 2021

SELL
$7.6 - $10.28 $188,814 - $255,396
-24,844 Closed
0 $0
Q2 2020

Aug 17, 2020

BUY
$21.19 - $40.2 $62,616 - $118,791
2,955 Added 13.5%
24,844 $533,000
Q1 2020

May 13, 2020

BUY
$32.32 - $58.37 $12,378 - $22,355
383 Added 1.78%
21,889 $811,000
Q4 2019

Feb 14, 2020

BUY
$25.0 - $92.22 $421,000 - $1.55 Million
16,840 Added 360.91%
21,506 $1.21 Million
Q3 2019

Nov 15, 2019

BUY
$15.73 - $41.6 $3,366 - $8,902
214 Added 4.81%
4,666 $144,000
Q2 2019

Aug 14, 2019

BUY
$14.16 - $20.64 $63,040 - $91,889
4,452 New
4,452 $67,000

Others Institutions Holding NXTC

About NextCure, Inc.


  • Ticker NXTC
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 27,748,800
  • Market Cap $20.8M
  • Description
  • NextCure, Inc., a clinical-stage biopharmaceutical company, engages in discovering and developing novel immunomedicines to treat cancer and other immune-related diseases by restoring normal immune function. Its lead product candidate is NC318, which is in Phase II clinical trials for the treatment of advanced or metastatic solid tumors. The comp...
More about NXTC
Track This Portfolio

Track California State Teachers Retirement System Portfolio

Follow California State Teachers Retirement System and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of California State Teachers Retirement System, based on Form 13F filings with the SEC.

News

Stay updated on California State Teachers Retirement System with notifications on news.